InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,166.40
(
0.51%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.37%
)
Bitcoin
65,717.63
(
-1.56%
)
Post# of 7234
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Frankestin

Send PM Follow Ignore
Followers 8
Posts 1912
Boards Moderated 0
Alias Born 09/10/2012

Frankestin

Re: None

Tuesday, 03/01/2022 3:09:44 AM

Tuesday, March 01, 2022 3:09:44 AM

Post# of 7234
Food for thought!
We have Robocop in command:
We are fully funded for commercial launch, following our debt and royalty transactions with DRI, and we look forward to providing VONJO, the potential best-in-class therapy for cytopenic myelofibrosis patients, to patients within 10 days," said Adam R. Craig

I am very convinced that he will make the most of everything without wasting anything.

Now that trust with the FDA has been restored it is logical to expect agreements to launch in the EU

https://www.businesswire.com/news/home/20131115005117/en/Baxter-and-Cell-Therapeutics-Announce-Worldwide-Strategic-Collaboration-to-Develop-and-Commercialize-Pacritinib
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up